PAK2 and breast carcinoma: It inhibits the cell proliferation and metastasis by targeting Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3)-mediated EMT process in GC and by targeting p21-activated protein kinase 2 (PAK2) in breast cancer.